441
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of oral sildenafil in treatment of pediatric head and neck lymphatic malformations

, , , , , , , , & show all
Pages 674-678 | Received 04 Oct 2016, Accepted 02 Dec 2016, Published online: 17 Jan 2017

References

  • Wiegand S, Eivazi B, Zimmermann AP, Sesterhenn AM, Werner JA. Sclerotherapy of lymphangiomas of the head and neck. Head Neck 2011;33:1649–55.
  • Colbert SD, Seager L, Haider F, Evans BT, Rajiv A, Brennan PA. Lymphatic malformations of the head and neck-current concepts in management. Br J Oral Maxillofac Surg 2013;51:98–102.
  • Jaiswal AA, Garg AK, Ravindranath M, Sarkar J, Mohanty MK. A huge congenital cervical lymphangioma:Case report with review of literature. Esentas 2015;16:283–90.
  • O TM, Rickert SM, Diallo AM, Scheuermann-Poley C, Otokiti A, Hong M, et al Lymphatic malformations of the airway. Otolaryngol Head Neck Surg 2013;149:156–60.
  • Erikci V, Hosgor M, Yildiz M, Ornek Y, Aksoy N, Okur O, et al. Intralesional bleomycin sclerotherapy in childhood lymphangioma. Turk J Pediatr 2013;55:396.
  • Cheng J. Doxycycline sclerotherapy in children with head and neck lymphatic malformations. J Pediatr Surg 2015;50:2143–6.
  • Makni A, Chebbi F, Fetirich F, Ksantini R, Bedioui H, Jouini M, et al. Surgical management of intra-abdominal cystic lymphangioma. Report of 20 cases. World J Surg 2012;36:1037–43.
  • Adams MT, Saltzman B, Perkins JA. Head and neck lymphatic malformation treatment a systematic review. Otolaryngol Head Neck Surg 2012;147:627–39.
  • Kimura M, Higashi Y, Hara K, Noma K, Sasaki S, Nakagawa K, et al. PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers. Hypertension 2003;41:1106–10.
  • Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8:47–52.
  • Swetman GL, Berk DR, Vasanawala SS, Feinstein JA, Lane AT, Bruckner AL. Sildenafil for severe lymphatic malformations. N Engl J Med 2012;366:384–6.
  • Danial C, Tichy AL, Tariq U, Swetman GL, Khuu P, Leung TH, et al. An open-label study to evaluate sildenafil for the treatment of lymphatic malformations. J Am Acad Dermatol 2014;70:1050–7.
  • Singh P, Mundy D. Giant neonatal thoraco-abdominal lymphatic malformations treated with sildenafil: a case report and review of the literature. J Perinat Med 2013;6:89–92.
  • George R, Shah R, Bulas D, Kline S, Alexander S, Reilly BK. The delivered promise of prenatal imaging and a challenge to the utility of sildenafil for severe lymphatic malformations. Int J Pediatr Otorhinolaryngol 2015;79:89–93.
  • Rankin H, Zwicker K, Trenor CC. Caution is recommended prior to sildenafil use in vascular anomalies. Pediatr Blood Cancer 2015;62:2015–7.
  • Ardicli B, Karnak I, Ciftci AO, Tanyel FC, Senocak ME. Sclerotherapy with bleomycin versus surgical excision for extracervical cystic lymphatic malformations in children. Surg Today 2016;46:97–101.
  • Bajaj Y, Hewitt R, Ifeacho S, Hartley BE. Surgical excision as primary treatment modality for extensive cervicofacial lymphatic malformations in children. Int J Pediatr Otorhi 2011;75:673–7.
  • Reismann M, Ghaffarpour N, Luvall E, Jirmo AC, Winqvist O, Radtke J, et al. Dynamic Toll-like receptor expression predicts outcome of sclerotherapy for lymphatic malformations with OK-432 in children. J Surg Res 2014;187:197–201.
  • Wang KL, Chun RH, Kerschner JE, Sulman CG. Sympathetic neuropathy and dysphagia following doxycycline sclerotherapy. Int J Pediatr Otorhinolaryngol 2013;77:1613–6.
  • Koshy JC, Eisemann BS, Agrawal N, Pimpalwar S, Edmonds JL. Sildenafil for microcystic lymphatic malformations of the head and neck: a prospective study. Int J Pediatr Otorhinolaryngol 2015;79:980–2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.